Hypertension Diagnostics Inc. (HDII)

Overview

Hypertension Diagnostics, Inc., founded in 1988 and headquartered in Richmond Hill, Canada, is a pioneer in the healthcare industry, specializing in the design, development, manufacture, and international marketing of innovative noninvasive medical devices. These devices are pivotal in detecting subtle changes in arterial elasticity, serving as a crucial indicator for cardiovascular diseases. With a strong presence both in the United States and internationally, the company leverages cutting-edge technology to empower physicians with accurate, non-invasive tools for assessing the health of arteries, emphasizing the early detection and sensitive markers of cardiovascular disease.

Products and Services

• CVProfilor DO-2020

This device is at the forefront of Hypertension Diagnostics' offerings, providing important arterial elasticity indices that help in the evaluation and management of underlying vascular diseases. Its non-invasive approach allows for an efficient assessment of both small and large artery elasticity, highlighting its pivotal role in the early detection of cardiovascular conditions.

• CVProfilor MD-3000

Geared towards a more specialized application, the CVProfilor MD-3000 serves as a sensitive and specific guide in identifying blood vessel diseases. This device enhances the precision of cardiovascular health assessments, making it an invaluable tool for cardiologists and cardiovascular specialists.

• HD/PulseWave CR-2000

Designed with research and scientific investigation in mind, the HD/PulseWave CR-2000 system provides a non-invasive means to assess arterial elasticity. It is tailored for use by researchers and scientists across various disciplines and supports a broad spectrum of human research endeavors aimed at unraveling the intricacies of cardiovascular diseases. By collecting and analyzing 30 seconds of blood pressure waveform data, the device generates a comprehensive CVProfile report, encapsulating essential information such as blood pressure, heart rate, pulse pressure, body surface area, body mass index, and the critical C1-large and C2-small artery elasticity indices.

The company distributes its products through a dedicated representative organization within the United States, targeting a diverse clientele that includes primary care physicians, cardiologists, health care professionals, trained medical personnel, research investigators at academic medical research centers, government institutes, cardiovascular specialists, and pharmaceutical companies. This broad distribution channel underscores Hypertension Diagnostics' commitment to combating cardiovascular disease on multiple fronts, by equipping a wide array of healthcare and research professionals with cutting-edge, non-invasive diagnostic tools.